NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 41 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30 | +650.0% | 333,069 | +1943.2% | 0.00% | – |
| Q1 2023 | $4 | -42.9% | 16,301 | -51.6% | 0.00% | -100.0% |
| Q4 2022 | $7 | -99.9% | 33,654 | -11.9% | 0.00% | 0.0% |
| Q3 2022 | $10,000 | -9.1% | 38,211 | +163.8% | 0.00% | 0.0% |
| Q1 2022 | $11,000 | -56.0% | 14,483 | -42.5% | 0.00% | -66.7% |
| Q4 2021 | $25,000 | -63.8% | 25,209 | +43.3% | 0.00% | -62.5% |
| Q2 2020 | $69,000 | +430.8% | 17,586 | -7.5% | 0.01% | +700.0% |
| Q3 2019 | $13,000 | -68.3% | 19,011 | -70.6% | 0.00% | -50.0% |
| Q2 2019 | $41,000 | – | 64,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Allred Capital Management, LLC | 65,303 | $176,000 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,540 | $358,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 51,648 | $139,000 | 0.00% |
| PATHSTONE FAMILY OFFICE, LLC | 10,050 | $28,000 | 0.00% |
| LifePlan Financial Group, Inc | 1,440 | $4,000 | 0.00% |
| Sowell Financial Services LLC | 11,234 | $30,000 | 0.00% |
| Jacobi Capital Management LLC | 1,000 | $3,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 65,089 | $176,000 | 0.00% |
| Sound Income Strategies, LLC | 599 | $2,000 | 0.00% |
| UBS Group AG | 1,785 | $5,000 | 0.00% |